MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 565545 | Name: QD-1

Description:

WARNING: This product is for research use only, not for human or veterinary use.

QD-1 is a antiproliferative, selectively binding to plec-1

Chemical Structure

QD-1
QD-1
CAS#N/A

Theoretical Analysis

MedKoo Cat#: 565545

Name: QD-1

CAS#: N/A

Chemical Formula: C21H13N3O3

Exact Mass: 355.0957

Molecular Weight: 355.35

Elemental Analysis: C, 70.98; H, 3.69; N, 11.83; O, 13.51

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
QD-1; QD 1; QD1
IUPAC/Chemical Name
6-(4-Benzoyl-phenylamino)-quinazoline-5,8-dione
InChi Key
PHAAGLFDGHGORP-UHFFFAOYSA-N
InChi Code
InChI=1S/C21H13N3O3/c25-18-10-17(21(27)16-11-22-12-23-19(16)18)24-15-8-6-14(7-9-15)20(26)13-4-2-1-3-5-13/h1-12,24H
SMILES Code
O=C(C(NC1=CC=C(C(C2=CC=CC=C2)=O)C=C1)=C3)C4=CN=CN=C4C3=O
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>3 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 355.35 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Groenland SL, Katz D, Huitema ADR, Steeghs N. Harnessing soft tissue sarcoma with low-dose pazopanib - a matter of blood levels. BMC Cancer. 2018 Dec 3;18(1):1200. doi: 10.1186/s12885-018-5043-9. PubMed PMID: 30509247; PubMed Central PMCID: PMC6276240. 2: Shams Khorrami A, Rezai P. Oscillating dispersed-phase co-flow microfluidic droplet generation: jet length reduction effect. Soft Matter. 2018 Dec 12;14(48):9870-9876. doi: 10.1039/c8sm02098a. PubMed PMID: 30474087. 3: Salerno G, Scarano S, Mamusa M, Consumi M, Giuntini S, Macagnano A, Nativi S, Fragai M, Minunni M, Berti D, Magnani A, Nativi C, Richichi B. A small heterobifunctional ligand provides stable and water dispersible core-shell CdSe/ZnS quantum dots (QDs). Nanoscale. 2018 Nov 1;10(42):19720-19732. doi: 10.1039/c8nr05566a. PubMed PMID: 30256371. 4: Ma M, Zhang M, Qiu Z. Eosinophilic meningitis caused by Angiostrongylus cantonensis in an infant: A case report. Medicine (Baltimore). 2018 Jun;97(24):e10975. doi: 10.1097/MD.0000000000010975. PubMed PMID: 29901586; PubMed Central PMCID: PMC6024093. 5: Bel Haj Mohamed N, Ben Brahim N, Mrad R, Haouari M, Ben Chaâbane R, Negrerie M. Use of MPA-capped CdS quantum dots for sensitive detection and quantification of Co(2+) ions in aqueous solution. Anal Chim Acta. 2018 Oct 22;1028:50-58. doi: 10.1016/j.aca.2018.04.041. Epub 2018 Apr 27. PubMed PMID: 29884353. 6: Luo R, Bozigian H, Jimenez R, Loewen G, O'Brien CF. Single Dose and Repeat Once-Daily Dose Safety, Tolerability and Pharmacokinetics of Valbenazine in Healthy Male Subjects. Psychopharmacol Bull. 2017 Aug 1;47(3):44-52. PubMed PMID: 28839339; PubMed Central PMCID: PMC5546550. 7: Yu W, Ji J, Xiao T, Ying C, Fang J, Shen P, Xiao Y. Determining optimal dosing regimen of oral administration of dicloxacillin using Monte Carlo simulation. Drug Des Devel Ther. 2017 Jun 28;11:1951-1956. doi: 10.2147/DDDT.S139632. eCollection 2017. PubMed PMID: 28721014; PubMed Central PMCID: PMC5500557. 8: Mu Y, Pan C, Fan B, Hehnke U, Zhang X, Zhang X, Wang X, Liu J, Zhang Y, Du J, Ma J, Gong Y. Efficacy and safety of linagliptin/metformin single-pill combination as initial therapy in drug-naïve Asian patients with type 2 diabetes. Diabetes Res Clin Pract. 2017 Feb;124:48-56. doi: 10.1016/j.diabres.2016.11.026. Epub 2016 Dec 5. PubMed PMID: 28088030. 9: Peng L, He M, Chen B, Qiao Y, Hu B. Metallomics Study of CdSe/ZnS Quantum Dots in HepG2 Cells. ACS Nano. 2015 Oct 27;9(10):10324-34. doi: 10.1021/acsnano.5b04365. Epub 2015 Sep 30. PubMed PMID: 26389814. 10: Faivre SJ, Olszanski AJ, Weigang-Köhler K, Riess H, Cohen RB, Wang X, Myrand SP, Wickremsinhe ER, Horn CL, Ouyang H, Callies S, Benhadji KA, Raymond E. Phase I dose escalation and pharmacokinetic evaluation of two different schedules of LY2334737, an oral gemcitabine prodrug, in patients with advanced solid tumors. Invest New Drugs. 2015 Dec;33(6):1206-16. doi: 10.1007/s10637-015-0286-7. Epub 2015 Sep 16. PubMed PMID: 26377590. 11: Wang B, Roth JA, Nguyen H, Felber E, Furnback W, Garrison LP. The short-term cost-effectiveness of once-daily liraglutide versus once-weekly exenatide for the treatment of type 2 diabetes mellitus in the United States. PLoS One. 2015 Apr 7;10(4):e0121915. doi: 10.1371/journal.pone.0121915. eCollection 2015. PubMed PMID: 25849542; PubMed Central PMCID: PMC4388383. 12: Frost C, Nepal S, Byon W, Moore K, Reeves RA, Boyd R, LaCreta F. Randomized, blinded, placebo- and positive-controlled crossover study to determine the effect of multiple doses of apixaban on the QTc interval. J Clin Pharmacol. 2015 May;55(5):549-55. doi: 10.1002/jcph.447. Epub 2015 Jan 14. PubMed PMID: 25501868. 13: Lanzafame M, Lattuada E, Rigo F, Hill A, Vento S. Efficacy of a reduced dose of DARUNAVIR/RTV in a cohort of antiretroviral-naïve and experienced HIV-infected patients: a medium-term follow-up. J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19822. doi: 10.7448/IAS.17.4.19822. eCollection 2014. PubMed PMID: 25397566; PubMed Central PMCID: PMC4225444. 14: Si C, Zhang Y, Lv X, Yang W, Ran Z, Sun P. In vivo lymph node mapping by Cadmium Tellurium quantum dots in rats. J Surg Res. 2014 Dec;192(2):305-11. doi: 10.1016/j.jss.2014.07.028. Epub 2014 Jul 19. PubMed PMID: 25193580. 15: Stass H, Weimann B, Nagelschmitz J, Rolinck-Werninghaus C, Staab D. Tolerability and pharmacokinetic properties of ciprofloxacin dry powder for inhalation in patients with cystic fibrosis: a phase I, randomized, dose-escalation study. Clin Ther. 2013 Oct;35(10):1571-81. doi: 10.1016/j.clinthera.2013.08.003. Epub 2013 Sep 18. PubMed PMID: 24054830. 16: Staehr PM, Dhalla AK, Zack J, Wang X, Ho YL, Bingham J, Belardinelli L. Reduction of free fatty acids, safety, and pharmacokinetics of oral GS-9667, an A(1) adenosine receptor partial agonist. J Clin Pharmacol. 2013 Apr;53(4):385-92. doi: 10.1002/jcph.9. Epub 2013 Feb 20. PubMed PMID: 23427000. 17: Onuigbo MA. Renoprevention: A new concept for reengineering nephrology care--an economic impact and patient outcome analysis of two hypothetical patient management paradigms in the CCU. Ren Fail. 2013;35(1):23-8. doi: 10.3109/0886022X.2012.741644. Epub 2012 Nov 15. PubMed PMID: 23151177. 18: Scott DA, Boye KS, Timlin L, Clark JF, Best JH. A network meta-analysis to compare glycaemic control in patients with type 2 diabetes treated with exenatide once weekly or liraglutide once daily in comparison with insulin glargine, exenatide twice daily or placebo. Diabetes Obes Metab. 2013 Mar;15(3):213-23. doi: 10.1111/dom.12007. Epub 2012 Oct 3. Review. PubMed PMID: 22958381. 19: Cremonini F, Nicandro JP, Atkinson V, Shringarpure R, Chuang E, Lembo A. Randomised clinical trial: alosetron improves quality of life and reduces restriction of daily activities in women with severe diarrhoea-predominant IBS. Aliment Pharmacol Ther. 2012 Sep;36(5):437-48. doi: 10.1111/j.1365-2036.2012.05208.x. Epub 2012 Jul 10. PubMed PMID: 22779693; PubMed Central PMCID: PMC3464357. 20: Ananworanich J, Gorowara M, Avihingsanon A, Kerr SJ, van Heesch N, Khongpetch C, Uanithirat A, Hill A, Ruxrungtham K, Burger DM; HIV-NAT 127 Study Team. Pharmacokinetics of and short-term virologic response to low-dose 400-milligram once-daily raltegravir maintenance therapy. Antimicrob Agents Chemother. 2012 Apr;56(4):1892-8. doi: 10.1128/AAC.05694-11. Epub 2012 Jan 17. PubMed PMID: 22252825; PubMed Central PMCID: PMC3318383.

View History

BAMF

BAMF

n-Decyl phosphoric acid

n-Decyl phosphoric acid

CZ-01179

CZ-01179

FA 2097

FA 2097

JAR1.39

JAR1.39

PA21A050

PA21A050